Ocugen Expands Ophthalmology Portfolio

MALVERN, Pa. & AURORA, Colo.--(BUSINESS WIRE)--Ocugen, a biopharmaceutical company developing treatments for sight-threatening diseases, announced that it licensed a clinical-stage asset from the UIC to be developed for the treatment of oGVHD.